Skip to main
OFIX

Orthofix International (OFIX) Stock Forecast & Price Target

Orthofix International (OFIX) Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 50%
Buy 25%
Hold 25%
Sell 0%
Strong Sell 0%

Bulls say

Orthofix Medical is well-positioned to experience continued growth due to its strong presence in the global spine market and its focus on providing innovative solutions for healthcare providers. With a diverse portfolio of products and services, the company is poised to benefit from the increasing demand for orthopedic and spine solutions. Furthermore, its solid financial performance, including a strong revenue and profit growth, exemplifies its ability to generate value for shareholders.

Bears say

Orthofix Medical is facing challenges with reimbursement for its bone growth stimulation products, leading to a downward adjustment in FY/26 guidance and the withdrawal of previous longer-term financial targets. While the company's Q1/26 revenue exceeded expectations, it did not provide further details on its performance and it is expected to be the low point for adjusted EBITDA and cash generation for the year. With the majority of its revenue coming from the global spine segment, these reimbursement challenges could significantly impact the company's financials and there are risks that the company may not meet revenue or earnings estimates to achieve its target price in the future.

Orthofix International (OFIX) has been analyzed by 4 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 25% recommend Buy, 25% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Orthofix International and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Orthofix International (OFIX) Forecast

Analysts have given Orthofix International (OFIX) a Buy based on their latest research and market trends.

According to 4 analysts, Orthofix International (OFIX) has a Buy consensus rating as of Sep 22, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $14.75, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $14.75, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Orthofix International (OFIX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.